NEW YORK, June 26, 2012 /PRNewswire/ -- A Product and Pipeline Analysis of the U.S. Type 2 Diabetes Mellitus Market

http://www.reportlinker.com/p0920065/A-Product-and-Pipeline-Analysis-of-the-US-Type-2-Diabetes-Mellitus-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

This research service presents a marketed and pipeline analysis of the U.S. type 2 diabetes mellitus market. According to the 2011 National Diabetes Fact Sheet, 25.8 million children and adults (or 8.3 percent of the population) in the United States suffer from diabetes. Type 2 diabetes mellitus is the most common form of diabetes; approximately 90 to 95 percent of diabetes patients suffer from type 2 diabetes mellitus. The purpose of this study is to highlight the current market landscape, and provide a competitive analysis of all marketed and pipeline drugs in development for type 2 diabetes mellitus. Dashboard slides are provided for all marketed and Phase 3 drugs in development for type 2 diabetes mellitus.

2. Introduction

Market Overview - Segmentation

3. Competitive Landscape

Type 2 Diabetes Competitive Landscape - Orals

Type 2 Diabetes Competitive Lanscape - Parenterals

Product Analysis - Orals

Product Analysis - Parenterals

Link:
A Product and Pipeline Analysis of the U.S. Type 2 Diabetes Mellitus Market